Strata Critical Medical (SRTA) Liabilities and Shareholders Equity (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $327.6 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $327.6 million, up 30.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 16.4% YoY), and the FY2025 annual result was $325.5 million, up 26.8% from the prior year.
• Liabilities and Shareholders Equity climbed to $327.6 million in Q1 2026 per SRTA's latest filing, from $325.5 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $335.1 million in Q3 2025 and troughed at $250.6 million in Q1 2025.
• A 5-year average of $303.3 million and a median of $320.2 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2024 and 2026: Liabilities and Shareholders Equity decreased 12.97% in 2024, then jumped 30.76% in 2026.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $325.0 million in 2022, then dropped by 9.26% to $294.9 million in 2023, then declined by 12.97% to $256.7 million in 2024, then rose by 26.8% to $325.5 million in 2025, then rose by 0.66% to $327.6 million in 2026.
• Business Quant data shows SRTA's Liabilities and Shareholders Equity at $327.6 million in Q1 2026, $325.5 million in Q4 2025, and $335.1 million in Q3 2025.